Histoplasmosis in human immunodeficiency virus patients

Divya E. Abraham, Sajiny John, Salim Surani, Reena Shah, Rahul Kashyap

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


In the U.S., Histoplasmosis caused by H. capsulatum is estimated to have around 15,000 new infections and 9000 deaths among people living with Human Immunodeficiency Virus (HIV)-PLHIV. It has been estimated that about half a million people acquire an infection per year and 100,000 develop disseminated one. An adequate diagnostic test with high sensitivity & specificity needs to be considered. The treatment of the infection, along with co-infection with T.B. and Histoplasmosis, Pneumocystis jirovecii (PJ) and Histoplasmosis and HIV needs to be managed appropriately. WHO's priority to have access to rapid testing and availability of treatment drugs for Histoplasmosis is notable.

Original languageEnglish
Title of host publicationHistoplasmosis
Subtitle of host publicationFrom Diagnosis to Treatment
PublisherNova Science Publishers, Inc.
Number of pages17
ISBN (Electronic)9798891132283
ISBN (Print)9798891131293
Publication statusPublished - 27 Nov 2023


  • AIDS
  • Amphotericin
  • Antigen
  • Diagnosis
  • EIA
  • HIV
  • Histoplasmosis
  • Itraconazole
  • Treatment


Dive into the research topics of 'Histoplasmosis in human immunodeficiency virus patients'. Together they form a unique fingerprint.

Cite this